SLC3A2 and acute myeloid leukemia: demonstrated that CD98hc promotes acute myelogenous leukemia (AML) propagation in mice models of disease by maintaining leukemic stem cells through the integrin signaling pathway, and genetic loss of CD98hc or antibody-mediated CD98hc blockage impairs in vivo AML propagation (56).